Evidence Question
What does direct evidence report when dulaglutide dose escalation is compared with tirzepatide for severe hypoglycemia?
Related to: HypoglycemiaShort answer
In indexed direct evidence at the reported timepoint, no difference was reported for severe hypoglycemia.
Why do we say this?
The available direct comparison reported no difference for this outcome at the reported timepoint, but the head-to-head evidence base is limited.
Explore the evidence
Related questions
- What does direct evidence report when dulaglutide dose escalation is compared with tirzepatide for incidence of gastrointestinal disorders?
- What does the evidence report about severe hypoglycemia with tirzepatide?
- What does the evidence report about severe hypoglycemia with dulaglutide dose escalation?